Ottobock, DE000BCK2223

Goldman cuts target to EUR 75 for Ottobock stock

Published on 10/27/2026 at 09:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Core revenue rose 11.70 percent in fiscal year 2025. Ottobock stock costs EUR 49.18 on October 27, 2026, 0.27 percent above the Xetra close.

Goldman and company milestones

  • Goldman Sachs cut its target from EUR 88.00 to EUR 75.00 on October 21, 2026.
  • Core revenue reached EUR 0.2 billion in fiscal year 2025, up 11.70 percent.
  • Ottobock stock trades at EUR 49.18 at 9:46 a.m. CEST at Lang & Schwarz on October 27, 2026, 0.27 percent above the Xetra close of October 26, 2026.
Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock stock (ISIN DE000BCK2223) was trading at EUR 49.18 at Lang & Schwarz on October 27, 2026, at 9:46 a.m. CEST, 0.27 percent above the Xetra close of October 26, 2026. The latest catalyst is a Goldman Sachs target cut that leaves the Buy rating intact.

Why Goldman cut the target

According to BORSE ONLINE on October 21, 2026, Goldman Sachs lowered its target from EUR 88.00 to EUR 75.00 while maintaining its Buy recommendation. Analyst Richard Felton expected weaker third-quarter revenue growth, citing continued weakness in North America.

The target remains EUR 25.82, or 52.50 percent, above the Lang & Schwarz price. That gap gives the analyst view a constructive medium-term angle, but the forecast also points to a near-term test for Ottobock's growth profile.

What does the business track record show?

Ottobock's investor-relations page reports core revenue of EUR 0.2 billion in fiscal year 2025, up 11.70 percent. Adjusted core EBITDA reached EUR 52.5 million, an increase of 29.50 percent, while adjusted group profit rose to EUR 22.4 million, up 83.20 percent, according to Ottobock.

Three dates shape the next phase

The company listed almost 9,300 full-time employees and more than 430 patient-care centers on June 24, 2026. On August 13, 2026, its investor-relations page highlighted fiscal 2025 core revenue of EUR 0.2 billion. On October 21, 2026, Goldman Sachs cut its target to EUR 75.00 while keeping Buy, as BORSE ONLINE reported.

Ottobock's next substantiated dates are November 12, 2026, for its third-quarter report, and November 16, 2026, for the BNP Paribas MidCap CEO Conference, according to Ottobock. The report should provide the first direct test of the North America concern behind the target revision.

Stock stays near its recent lows

The Lang & Schwarz quote places Ottobock stock only EUR 3.62 above the all-time low of EUR 45.56 cited by dpa-AFX on October 21, 2026. The current session change is modest, so the analyst revision and the November reporting date remain the more important reference points.

Ottobock was trading at EUR 49.18 at Lang & Schwarz on October 27, 2026, at 9:46 a.m. CEST, plus 0.27 percent versus the Xetra close of October 26, 2026 at EUR 49.05. The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.

Ottobock stock facts

  • Company: Ottobock SE & Co. KGaA
  • ISIN: DE000BCK2223
  • WKN: BCK222
  • Ticker: OBCK
  • Primary exchange: Xetra
  • Price Lang & Schwarz as of October 27, 2026, 9:46 a.m. CEST: EUR 49.18
  • Change versus Xetra close: plus 0.27 percent
  • Xetra close October 26, 2026: EUR 49.05
  • Sector / Industry: Medical technology

Market context: Market report DAX.

More news and analyses on Ottobock stock

Disclaimer...
en | DE000BCK2223 | OTTOBOCK | boerse | 70418767 |